By Martin Baccardax “As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid,” said CEO Albert Bourla. Pfizer (PFE) – Get Pfizer Inc. Report said Thursday that it’s submitted a new application to the U.S. Food & Drug Administration seeking formal approval for the sale of its Covid oral treatment Paxlovid. Pfizer said the New Drug Application (NDA) request would apply to patients who are at ‘high risk’ in terms of progressing to severe illness from Covid 19. That would essentially…